QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.105.006890v1 34/1/16    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vyas, P. M. Articles by Svensson, C. K. Search for Related Content PubMed PubMed Citation Articles by Vyas, P. M. Articles by Svensson, C. K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB DAPSONE ETHYLENEDIAMINE TETRAACETIC ACID HYDROGEN PEROXIDE SULFAMETHOXAZOLE

SHORT COMMUNICATION

ROLE OF HUMAN CYCLOOXYGENASE-2 IN THE BIOACTIVATION OF DAPSONE AND SULFAMETHOXAZOLE

Division of Pharmaceutics, College of Pharmacy, The University of Iowa, Iowa City, Iowa

Sulfamethoxazole (SMX) and dapsone (4,4'-diaminodiphenylsulfone, DDS) are believed to mediate their adverse effects subsequent to bioactivation to their respective arylhydroxylamine and arylnitroso metabolites, resulting in covalent adduct formation with intracellular proteins. Various bioactivating enzymes, such as cytochromes P450 and myeloperoxidase, have been shown to be capable of catalyzing the N-oxidation of these compounds. We assessed the role of human cyclooxygenase-2 (COX-2) in the metabolism and subsequent adduct formation of DDS and SMX using recombinant human COX-2. Using an adduct-specific enzyme-linked immunosorbent assay, we found that the complete enzyme system gave rise to covalent adducts. However, the nonspecific COX inhibitor indomethacin did not reduce the amount of covalent adduct formed. Formation of the arylhydroxylamine metabolites was demonstrated via high performance liquid chromatography coupled with UV absorption. Metabolite formation was found to be secondary to the H₂O₂ in the incubation mixture and was not enzyme-mediated. Hence, COX-2 does not play a direct role in the bioactivation of these parent drugs to their arylhydroxylamine metabolites.

This article has been cited by other articles:

				S. N. Lavergne, H. Wang, H. E. Callan, B. K. Park, and D. J. Naisbitt "Danger" Conditions Increase Sulfamethoxazole-Protein Adduct Formation in Human Antigen-Presenting Cells J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 372 - 381. [Abstract] [Full Text] [PDF]

				J. P. Sanderson, F. J. Hollis, J. L. Maggs, S. E. Clarke, D. J. Naisbitt, and B. K. Park Nonenzymatic Formation of a Novel Hydroxylated Sulfamethoxazole Derivative in Human Liver Microsomes: Implications for Bioanalysis of Sulfamethoxazole Metabolites Drug Metab. Dispos., December 1, 2008; 36(12): 2424 - 2428. [Abstract] [Full Text] [PDF]

				J. P. Sanderson, D. J. Naisbitt, J. Farrell, C. A. Ashby, M. J. Tucker, M. J. Rieder, M. Pirmohamed, S. E. Clarke, and B. K. Park Sulfamethoxazole and Its Metabolite Nitroso Sulfamethoxazole Stimulate Dendritic Cell Costimulatory Signaling J. Immunol., May 1, 2007; 178(9): 5533 - 5542. [Abstract] [Full Text] [PDF]

				P. M. Vyas, S. Roychowdhury, F. D. Khan, T. E. Prisinzano, J. Lamba, E. G. Schuetz, J. Blaisdell, J. A. Goldstein, K. L. Munson, R. N. Hines, et al. Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: I. Expression and Role of Cytochromes P450 J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 488 - 496. [Abstract] [Full Text] [PDF]

				P. M. Vyas, S. Roychowdhury, S. B. Koukouritaki, R. N. Hines, S. K. Krueger, D. E. Williams, W. M. Nauseef, and C. K. Svensson Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: II. Expression and Role of Flavin-Containing Monooxygenases and Peroxidases J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 497 - 505. [Abstract] [Full Text] [PDF]